TDSPharma is drawing market attention as a Volatility Interruption (VI) was triggered during trading hours.

According to the Korea Exchange on the 30th, a dynamic VI was triggered for TDSPharma at 2:14:46 PM at 6,420 won. The dynamic VI reference price was 6,040 won, meaning the device was activated at a level 6.29% above the reference.

TDSPharma is a company that holds the Transdermal Drug Delivery System (TDDS) as its core technology, which delivers drugs into the body through the skin. The company is focusing on developing patient-friendly formulations that convert existing oral administration methods into patch forms to ensure safety and efficacy.

Based on skin permeation enhancement technology, various patch structure design technologies, drug release control technology, and manufacturing process technology, the company is engaged in the research, development, and production of pharmaceuticals and cosmetics. Its KGMP production facility with a strict quality control system supplying various products to domestic and international partners is also evaluated as a competitive advantage.

Market analysis suggests that as the aging population and chronic diseases increase, the market for patch-type pharmaceuticals that improve medication convenience is expected to grow, and interest in companies with drug delivery platform technology continues.

However, VI is a market stabilization device designed to mitigate short-term stock price volatility and does not indicate future stock price direction. Future stock price trends are expected to be influenced by new product development results, financial performance, technological competitiveness, and investor sentiment.

[This article was written with the assistance of AI. This article is not intended to solicit investment, and the final decision and responsibility for investment lie with the investor.]